Ernexa Therapeutics Inc. - Common Stock (ERNA)

CUSIP: 114082209

Q3 2024 13F Holders as of 30 Sep 2024

Security identity
Shares outstanding
1,166,181
Holder snapshot
Share change
+321,274
Reported price per share
$1.05
Number of holders
20
Value change
+$337,331
Number of buys
4
Number of sells
4

Security key

114082209

Report period

Q3 2024

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of ERNA - Ernexa Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Cypress Point Wealth Mana...
13D/G signal
Evidence rows
15
Latest as of
30 Jun 2024
13F Lead comparable stake: 8.1% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Cypress Point Wealth Management, LLC
13F
Company
13F
8.1%
$172,707
94,375 shares
30 Jun 2024
Naviter Wealth, LLC
13F
Company
13F
6.8%
$144,197
78,796 shares
30 Jun 2024
Sippican Capital Advisors
13F
Company
13F
6.2%
$133,224
72,800 shares
30 Jun 2024
Corient Private Wealth LLC
13F
Company
13F
4.3%
$91,220
50,398 shares
30 Jun 2024
VANGUARD GROUP INC
13F
Company
13F
2.2%
$47,761
26,099 shares
30 Jun 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
2%
$42,959
23,719 shares
30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
711,299
Rows available
20
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
19
Q3 2024 holders
20
Holder diff
1
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .